Max Robotics — Global Service Robot Directory + US Certification

About

H. Mirghani is a leading figure in head and neck surgical oncology, with a particular focus on transoral robotic surgery (TORS) and the management of salivary gland malignancies. Their work has significantly advanced minimally invasive approaches for complex tumors, as demonstrated in their landmark multicenter REFCOR study, which evaluated TORS for salivary carcinomas of the base of tongue. This research, published in 2025, has already garnered 2 citations, underscoring its immediate impact on clinical practice and surgical decision-making. Mirghani’s contributions extend beyond technique refinement, encompassing the integration of robotic platforms to improve functional outcomes and reduce morbidity in patients with oropharyngeal cancers. Their collaborative efforts within the French REFCOR network highlight a commitment to evidence-based, multi-institutional research that shapes treatment guidelines. By pioneering safer, more precise surgical alternatives, Mirghani has enhanced the therapeutic landscape for head and neck cancer patients, offering hope for better quality of life post-treatment. Their work continues to inspire surgeons and researchers exploring the frontiers of robotic-assisted oncology.